
Sign up to save your podcasts
Or


As COVID vaccines become more accessible to the public, it's important to keep in mind the present dangers of other common respiratory illnesses. Transmission of these infections affects everyone, from Baby Boomers to Gen Zers, in various ways that could be fatal for some but a cough to others. Dr. Angela Rasmussen joins us to discuss testing and transmission regarding influenza, respiratory syncytial virus (RSV), and COVID-19.
Hosted by:
Silvia Quevedo, CAE
About our Guest:
Angela L. Rasmussen, Ph.D
Angela L. Rasmussen, Ph.D. is a virologist currently affiliated with the Georgetown Center for Global Health Science and Security. In spring 2021, Dr. Rasmussen will also be starting a lab at the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), a vaccine research institute at the University of Saskatchewan. Dr. Rasmussen is a member of the Verena Consortium, a multi-disciplinary, international effort to predict and study emerging viral pathogens. Dr. Rasmussen studies the role of the host response in emerging virus pathogenesis, with a particular interest in viruses that are or have the potential to be major threats to global health, such as influenza, dengue, Ebola, MERS-CoV, and SARS-CoV-2.
By Association for Professionals in Infection Control and Epidemiology (APIC)4.5
3737 ratings
As COVID vaccines become more accessible to the public, it's important to keep in mind the present dangers of other common respiratory illnesses. Transmission of these infections affects everyone, from Baby Boomers to Gen Zers, in various ways that could be fatal for some but a cough to others. Dr. Angela Rasmussen joins us to discuss testing and transmission regarding influenza, respiratory syncytial virus (RSV), and COVID-19.
Hosted by:
Silvia Quevedo, CAE
About our Guest:
Angela L. Rasmussen, Ph.D
Angela L. Rasmussen, Ph.D. is a virologist currently affiliated with the Georgetown Center for Global Health Science and Security. In spring 2021, Dr. Rasmussen will also be starting a lab at the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), a vaccine research institute at the University of Saskatchewan. Dr. Rasmussen is a member of the Verena Consortium, a multi-disciplinary, international effort to predict and study emerging viral pathogens. Dr. Rasmussen studies the role of the host response in emerging virus pathogenesis, with a particular interest in viruses that are or have the potential to be major threats to global health, such as influenza, dengue, Ebola, MERS-CoV, and SARS-CoV-2.

91,000 Listeners

78,459 Listeners

30,695 Listeners

37,506 Listeners

11,976 Listeners

11,778 Listeners

10,769 Listeners

112,416 Listeners

16,909 Listeners

9,349 Listeners

47,413 Listeners

6,397 Listeners

17,726 Listeners

2 Listeners

15 Listeners